About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Ohio | 986 Studies

Clinical Trials Breast CancerOhio

Breast Cancer Clinical Trials in Ohio

Find 986 clinical trials for breast cancer near Ohio. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 801-820 of 986 trials

Not yet recruitingStudying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer HospitalThis study examines how the American College of Surgeons Geriatric Surgery Verification Program, also called the ACS GSV Program, is implemented at the James Cancer Hospital.NCT07606287·Columbus, Ohio Active not recruitingProspective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)This is a pilot study to determine safety, efficacy, and potential risks of robot assisted nipple sparing mastectomy (RNSM), by utilizing the daVinci surgical system.NCT04537312·Columbus, Ohio

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingStudy of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast CancerThe purpose of this research study is to determine the safety, tolerability and dose of Ribociclib when combined with adjuvant radiation in women with high-risk ER+ breast cancer.NCT05996107·Ann Arbor, Michigan and 2 others

TerminatedTherapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerThe purpose of this study is to evaluate the efficacy and safety of an adjuvant treatment of therapeutic cancer vaccine (AST-301, pNGVL3-hICD) in patients with HER2-low expression…NCT05163223·Chandler, Arizona and 16 others

CompletedPilocarpine in Treating Vaginal Dryness in Patients With Breast CancerRATIONALE: Pilocarpine may decrease vaginal dryness and improve quality of life in patients with breast cancer It is not yet known whether pilocarpine is more effective than a…NCT00343382·Aurora, Colorado and 191 others

CompletedT-DM1 and Palbociclib for Metastatic HER2 Breast CancerThis is a single arm, phase II study to evaluate if the combination of T-DM1 with palbociclib improves progression-free survival in patients with metastatic HER2 positive breast…NCT03530696·Tucson, Arizona and 15 others

Active not recruitingCognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsThis Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.NCT05896189·Anchorage, Alaska and 679 others

WithdrawnBreast Reconstruction Following Breast Cancer in Very High Risk PatientsThe purpose of this study is to: 1.NCT03261323·Cleveland, Ohio

CompletedIncidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerThis clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer.NCT01139957·Birmingham, Alabama and 140 others

CompletedTamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells.NCT01124695·Birmingham, Alabama and 293 others

TerminatedA Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid TumorsThis is an open-label Phase 1b/2 multicenter study of rebastinib (DCC-2036) in combination with carboplatin designed to evaluate the safety, tolerability, and pharmacokinetics…NCT03717415·San Francisco, California and 8 others

CompletedGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerThis phase I trial studies the side effects and the best dose of gamma-secretase inhibitor RO4929097 when given together with paclitaxel and carboplatin in patients with stage II…NCT01238133·Columbus, Ohio

CompletedDoxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004067·Huntsville, Alabama and 148 others

CompletedRandomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast CancerThis study will test the theory that therapy designed for each individual's tumor will improve outcomes over standard of care in a population that needs a better standard.NCT02101385·Birmingham, Alabama and 28 others

Active not recruitingA Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast CancerThis research study is studying a combination of HER2-directed therapies (trastuzumab and pertuzumab) and hormonal therapy as a treatment after surgery for hormone receptor…NCT04569747·Stamford, Connecticut and 31 others

RecruitingA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyThis is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants who are currently…NCT04641247·Tucson, Arizona and 24 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

RecruitingLiving Well With Advanced Breast CancerThis study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they…NCT07227038·Columbus, Ohio

CompletedA Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerThis study was a Phase III, randomized, double-blind, placebo-controlled, multicenter international clinical trial conducted to investigate the use of pertuzumab in combination…NCT00567190·Scottsdale, Arizona and 321 others

WithdrawnProton Accelerated Partial Breast IrradiationThis prospective, non-randomized phase II study will evaluate the cosmetic outcome of using pencil beam scanning proton therapy for partial breast irradiation in patients…NCT03940248·Cincinnati, Ohio

PreviousPage 41 of 50Next

Other Conditions in Ohio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma